Does serum CA-125 level prior to second-look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease?
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (3) , 319-322
- https://doi.org/10.1016/0090-8258(90)90359-s
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Abdominopelvic irradiation for persistent advanced ovarian carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival durationCancer, 1988
- Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinomaGynecologic Oncology, 1988
- A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancerGynecologic Oncology, 1988
- Another look at the second- assessment procedure for ovarian epithelial carcinomaAmerican Journal of Obstetrics and Gynecology, 1987
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- A critical reassessment of second-look laparotomy in epithelial ovarian carcinomaCancer, 1986
- Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1985
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983